Patents by Inventor Yves Sagot

Yves Sagot has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of IL-18BP isoforms for the treatment and/or prevention of neurological inflammatory diseases
    Patent number: 8128920
    Abstract: The invention relates to the use of an IL18-BP isoform that does not bind to IL18, or of an agonist thereof, for treatment or prevention of a neurological and/or inflammatory disease. Preferred isoforms for use in the frame of the invention include IL-18BPb and IL-18BPd.
    Type: Grant
    Filed: June 2, 2006
    Date of Patent: March 6, 2012
    Assignee: Merck Serono SA
    Inventors: Yves Sagot, Yolande Chvatchko, Anne Corbaz
  • Use of Il-17F for the Treatment and/or Prevention of Neurologic Diseases
    Publication number: 20080286227
    Abstract: The invention relates to the use of IL-17F, or of an agonist of IL-17F activity, for treatment or prevention of neurologic diseases.
    Type: Application
    Filed: September 21, 2005
    Publication date: November 20, 2008
    Applicant: Applied Research Systems ARS Holding N.V.
    Inventors: Yves Sagot, Sandrine Pouly
  • Use of Il-18Bp Isoforms for the Treatment and/or Prevention of Neurological Inflammatory Diseases
    Publication number: 20080233085
    Abstract: The invention relates to the use of an IL18-BP isoform that does not bind to IL18, or of an agonist thereof, for treatment or prevention of a neurological and/or inflammatory disease. Preferred isoforms for use in the frame of the invention include IL-18BPb and IL-18BPd.
    Type: Application
    Filed: June 2, 2006
    Publication date: September 25, 2008
    Applicant: Laboratoires Serono SA
    Inventors: Yves Sagot, Yolande Chvatchko, Anne Corbaz
  • Use of clusterin for the treatment and/or prevention of peripheral neurological diseases
    Publication number: 20070134260
    Abstract: The invention relates to the use of clusterin, or of an agonist of clusterin activity, for treatment or prevention of peripheral neurological diseases, The invention further relates to the use of a combination of clusterin and heparin, for treatment or prevention of peripheral neurological diseases.
    Type: Application
    Filed: March 26, 2004
    Publication date: June 14, 2007
    Inventors: Georg Feger, Ursula Boschert, Yves Sagot, Ruben Papoian